Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07146568 · ClinicalTrials.gov registry record · NA

Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hospital

A NA study of Lung Cancer and Cancer of the Lung, sponsored by Washington University School of Medicine.

Recruiting
Registry status
NA
Development phase
5,515
Enrollment target
1
Study location

NCT07146568: Recruiting NA study of Lung Cancer and Cancer of the Lung, sponsored by Washington University School of Medicine.

NCT07146568 is a NA study of Lung Cancer and Cancer of the Lung that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 5,515 participants, above the 922-participant average among 409 other Lung Cancer trials with a reported enrollment target (498% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07146568, a NA study of Lung Cancer and Cancer of the Lung, is actively recruiting participants, sponsored by Washington University School of Medicine.

RECRUITING
Registry status
NA
Development phase
5,515 participants
Enrollment target
1
Study location

Study Summary

Inspired by the ongoing Pink \& Pearl Campaign, the breast radiology service of Christian Hospital in north St. Louis County will partner with Siteman Cancer Center to pilot this campaign in its mammography clinics in order to promote awareness, referral, and completion of lung cancer screening (LCS) among eligible women. This campaign leverages established infrastructure such as nurse navigation and referral to screening or primary care for further shared decision-making on cancer screening. The purpose of this study is to evaluate the effectiveness of the Pink \& Pearl Campaign in improving LCS uptake among LCS-eligible women undergoing mammography at Christian Hospital. This evaluation is grounded in the Integrated Screening Action Model that depicts individual- and environmental-level influences on the screening behavior process. Using an explanatory sequential mixed methods design, which combines both quantitative and qualitative approaches, our specific aims for this proposal are to: a) assess whether the Pink \& Pearl Campaign increases referrals and uptake/completion of LCS among LCS-eligible women undergoing screening mammography; b) determine median time-to-screening after referral to LCS; and c) evaluate individual and health system factors influencing LCS uptake and implementation outcomes of the campaign. These implementation outcomes will help identify whether the campaign was put in place successfully or not. This proposal will inform strategies for integrating cancer screening programs to improve poorly performing programs like LCS.

Primary Outcome

The investigators will compare the baseline prevalence of LCS among women undergoing BCS to the prevalence of LCS among women undergoing BCS 6 months after implementation of the Pink \& Pearl Campaign.

Interventions

  • OTHER Pink and Pearl Campaign

Study Locations (1)

Missouri

  • Barnes-Jewish Christian Hospital - St Louis

Trial Details

FieldValue
Enrollment Target 5,515 participants
Start Date 2026-02-23
Est. Completion 2026-08-31
Phase NA

What NCT07146568 shows while recruiting

NCT07146568 is an interventional study that assigns participants to a tested intervention. Its 5,515 participants enrollment target places it among the larger protocols in the corpus, above the 922-participant average among 409 other Lung Cancer trials with a reported enrollment target (498% higher).

The record links to 2 conditions, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Pink and Pearl Campaign is the first listed.

NCT07146568 reports a single indexed study location in Missouri.

Frequently Asked Questions

What is clinical trial NCT07146568 about?

NCT07146568 is a clinical study titled "Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hospital". Inspired by the ongoing Pink \& Pearl Campaign, the breast radiology service of Christian Hospital in north St. Louis County will partner with Siteman Cancer Center to pilot this campaign in its mammography clinics in order to promote awareness, referral, and completion of lung cancer screening (LCS...

What is the current status of trial NCT07146568?

This trial is currently recruiting. It is a NA study. The enrollment target is 5,515 participants. The study started on 2026-02-23. Estimated completion is 2026-08-31.

What conditions does trial NCT07146568 study?

This clinical trial studies the following conditions: Lung Cancer, Cancer of the Lung.

What interventions are being tested in trial NCT07146568?

The interventions under investigation include: Pink and Pearl Campaign (OTHER).

Who is sponsoring clinical trial NCT07146568?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07146568 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07146568's enrollment target sits among peer trials

5,515 16th of 409 higher than 394 of 409 other Lung Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05952557 · 5,500 participants · Phase 3

    An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)

  • NCT06084234 · 5,500 participants · Phase 4

    National Liver Cancer Screening Trial

  • NCT04295486 · 5,478 participants · Phase 2

    Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty

  • NCT06981598 · 5,586 participants · NA

    Prevention of Psychological Health Problems Via Integrated Operational Support

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07146568, the US trial registry maintained by the National Library of Medicine. NCT07146568 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.